Riskpilot← Back to searchSign inGet full accessBOEL AKUPUNKTUR ApS
APSActiveCVR 86255219Industrivej Nord 22Traditional, complementary and alternative medicine activities · NACE 8696Est. 197923 employeeswww.boel-akupunktur.com
Revenue 2024
DKK 14,1M
+5% vs 2023
EBITDA margin
20.3%
+22% vs 2023
Equity ratio
58.9%
Financial strength
Net profit 2024
DKK 2,1M
+20% vs 2023
| Revenue | DKK 14,1M | +5% |
| EBITDA | DKK 2,9M | +22% |
| Net profit | DKK 2,1M | +20% |
| Total assets | DKK 4,9M | +1% |
| Equity | DKK 2,9M | +16% |
| Employees | 23 | — |
Legal name
BOEL AKUPUNKTUR ApS
CVR number
86255219
Legal form
Anpartsselskab
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
4. maj 1979
Share capital
DKK 200.000
Employees
23 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene
Company purpose
Selskabets formål er at udøve virksomhed i form af privat hospital, alternativ helbredelse og øvrig hermed beslægtet virksomhed.
Address
Industrivej Nord 22
Phone
+4597875800
Email
info@boel-akupunktur.dk
Website
www.boel-akupunktur.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.123 | 1.301 | 2.670 | 3.466 | 6.424 | 8.451 | 8.636 | 8.427 | 9.077 | 9.970 | 12.384 | 13.348 | 14.079 |
| Staff expenses | -1.718 | -1.764 | -2.142 | -2.601 | -5.336 | -6.146 | -6.839 | -7.056 | -6.878 | -7.700 | -9.453 | -11.006 | -11.227 |
| EBITDA | 405 | -462 | 528 | 865 | 1.088 | 2.305 | 1.797 | 1.365 | 2.199 | 2.270 | 2.931 | 2.343 | 2.852 |
| Depreciation & amort. | -204 | -207 | -178 | -168 | -167 | -185 | -189 | -150 | -192 | -160 | -148 | -238 | -312 |
| EBIT | 201 | -669 | 350 | 697 | 921 | 2.119 | 1.608 | 1.215 | 2.006 | 2.110 | 2.783 | 2.104 | 2.540 |
| Net financials | -4 | -4 | -9 | 15 | 40 | 37 | 49 | 50 | 60 | 52 | 58 | 158 | 149 |
| Profit before tax | 196 | -673 | 341 | 712 | 962 | 2.157 | 1.657 | 1.265 | 2.067 | 2.163 | 2.841 | 2.262 | 2.690 |
| Tax | 50 | -136 | 78 | 162 | 212 | 475 | 365 | 279 | 457 | 475 | 629 | 521 | 593 |
| Net profit | 146 | -536 | 263 | 550 | 749 | 1.682 | 1.292 | 986 | 1.610 | 1.688 | 2.212 | 1.741 | 2.097 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.755 | 1.762 | 1.772 | 2.255 | 2.941 | 4.383 | 3.505 | 3.644 | 4.734 | 5.594 | 4.794 | 4.859 | 4.931 |
| Equity | 1.199 | 566 | 632 | 1.083 | 952 | 1.884 | 1.496 | 1.207 | 1.867 | 2.055 | 2.767 | 2.507 | 2.904 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 555 | 349 | 359 |
| Short-term debt | 557 | 1.196 | 1.140 | 1.173 | 1.989 | 2.499 | 1.979 | 2.425 | 2.867 | 3.539 | 1.473 | 2.003 | 1.614 |
| Total debt | 557 | 1.196 | 1.140 | 1.173 | 1.989 | 2.499 | 1.979 | 2.425 | 2.867 | 3.539 | 2.028 | 2.352 | 1.973 |
EBITDA margin
20.3%
This company
15.8%
Market median
+28% vs market
20122024
Equity ratio
58.9%
This company
38.2%
Market median
+54% vs market
20122024
Return on equity
72.2%
This company
18.4%
Market median
+292% vs market
20122024
Net profit margin
14.9%
This company
8.1%
Market median
+84% vs market
20122024
Asset turnover
2.86×
This company
1.12×
Market median
+155% vs market
20122024
Debt / equity
0.70×
This company
0.62×
Market median
+13% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OJ Audit | Audit | 1998 | — | — |
JB Management | Management | 1979 | — | — |
JB Management | Management | 2014 | — | — |
CE Management | Management | 2024 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
JBJR Holding ApS | Company | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JBJR Holding ApS
BOEL AKUPUNKTUR ApS Board members of BOEL AKUPUNKTUR ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ove Jens Rasmussen | Audit | 0 companies |
| John Boel | Management | 0 companies |
| John Boel | Management | 0 companies |
| Corinne Esther Boel | Management | 0 companies |